CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.
CytoVale's investors include Alumni Ventures, Norwest, Sands Capital Ventures, National Science Foundation, Blackhorn Ventures.
CytoVale is headquartered in South San Francisco, United States.
CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.
CytoVale is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CytoVale — Funding & Investors." VCBacked, April 15, 2025, https://www.vcbacked.co/company/cytovale. Accessed November 12, 2026.
VCBacked. (2025). CytoVale — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/cytovale
{{cite web |title=CytoVale — Funding & Investors |url=https://www.vcbacked.co/company/cytovale |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at CytoVale? Request a listing update